Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

Clinical trial NCT05962606 · COMPLETED

Trial details

NCT number: NCT05962606
Sponsor: Aptarion Biotech AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Community-acquired Pneumonia

Start date: 2024-02-02
Primary completion: 2026-03-16
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.